| Followers | 1130 |
| Posts | 32835 |
| Boards Moderated | 3 |
| Alias Born | 01/11/2016 |
Monday, April 20, 2020 5:11:15 PM
Possible huge asset buy, or outright buyout coming from GILD or even a partnership.
Recent RCUS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 08:09:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:11:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:09:18 PM
- Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update • Business Wire • 05/05/2026 08:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 04/24/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/21/2026 08:09:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:07:38 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:06:58 PM
- Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates • Business Wire • 04/21/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 11:56:39 AM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 04/09/2026 08:35:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 03/24/2026 08:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:46:13 AM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 03/09/2026 08:35:00 PM
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences • Business Wire • 02/26/2026 09:05:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/25/2026 09:39:51 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/25/2026 09:20:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/25/2026 09:11:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:08:03 PM
- Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update • Business Wire • 02/25/2026 09:05:00 PM
- Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer • Business Wire • 02/23/2026 10:00:00 PM
- Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates • Business Wire • 02/11/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 01:21:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 01:21:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 01:21:23 AM
